The Clorox Company logo

The Clorox Company (CLX)

Market Open
5 Dec, 18:00
NYSE NYSE
$
105. 00
-0.1
-0.1%
$
13.14B Market Cap
- P/E Ratio
4.88% Div Yield
515,573 Volume
- Eps
$ 105.1
Previous Close
Day Range
104.66 106.09
Year Range
98.2 171.37
Want to track CLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
Why Is Clorox (CLX) Down 4.1% Since Last Earnings Report?

Why Is Clorox (CLX) Down 4.1% Since Last Earnings Report?

Clorox (CLX) reported earnings 30 days ago. What's next for the stock?

Zacks | 2 days ago
The Clorox Company (CLX) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

The Clorox Company (CLX) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

The Clorox Company (CLX) Presents at Morgan Stanley Global Consumer & Retail Conference 2025 Transcript

Seekingalpha | 2 days ago
5 Must-Own Dividend Aristocrats That Can Weather a Coming Big Sell-Off

5 Must-Own Dividend Aristocrats That Can Weather a Coming Big Sell-Off

The recent high-velocity sell-off may be a preview of what's to come this year or in 2026.

247wallst | 2 weeks ago
Clorox: ERP Overhang Eases, Defense Appeal Remains, But Outlook Still Uncertain

Clorox: ERP Overhang Eases, Defense Appeal Remains, But Outlook Still Uncertain

The Clorox Company (CLX) is rated "Hold" with a 12-month price target of $120, implying a 10% upside excluding dividends. CLX faces headwinds from ERP transition, declining sales, and margin pressure, but most negatives appear priced in, limiting further downside risk. Management expects ERP challenges to ease after FY2026, potentially unlocking innovation, cost optimization, and margin recovery for CLX.

Seekingalpha | 4 weeks ago
Clorox Q1 Earnings Beat Estimates, Organic Sales Fall 17% Y/Y

Clorox Q1 Earnings Beat Estimates, Organic Sales Fall 17% Y/Y

CLX posts Q1 earnings and sales above estimates despite steep year-over-year declines tied to its U.S. ERP transition.

Zacks | 1 month ago
Clorox Q1: There Are Concerns Beyond Transitory ERP Weakness

Clorox Q1: There Are Concerns Beyond Transitory ERP Weakness

The Clorox Company reported very weak fiscal Q1 results. The company's ERP-related disruption caused most of the quarter's weakness. CLX's underlying consumption has also been weak. A weak consumer has caused below-usual category growth and competitive pressure from lower-cost substitutes. The quarter causes more cautious growth estimates for Clorox as the company struggles to grow market share and maintain pricing.

Seekingalpha | 1 month ago
Has Clorox Become A Value Stock?

Has Clorox Become A Value Stock?

Clorox (CLX) has seen a meaningful decline in its share price over the past year, pressured by post-pandemic normalization, rising input costs, and the aftereffects of the cyberattack that disrupted operations. Once viewed as a defensive growth name, the stock's premium valuation has faded as investor sentiment cooled.

Forbes | 1 month ago
Clorox (CLX) Q1 Earnings and Revenues Top Estimates

Clorox (CLX) Q1 Earnings and Revenues Top Estimates

Clorox (CLX) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $1.86 per share a year ago.

Zacks | 1 month ago
The Clorox Company (CLX) Q1 2026 Earnings Call Transcript

The Clorox Company (CLX) Q1 2026 Earnings Call Transcript

The Clorox Company ( CLX ) Q1 2026 Earnings Call November 3, 2025 5:00 PM EST Company Participants Lisah Burhan - Vice President of Investor Relations Linda Rendle - CEO & Chairman Luc Bellet - Executive VP & CFO Conference Call Participants Peter Grom - UBS Investment Bank, Research Division Andrea Teixeira - JPMorgan Chase & Co, Research Division Kaumil Gajrawala - Jefferies LLC, Research Division Filippo Falorni - Citigroup Inc., Research Division Christopher Carey - Wells Fargo Securities, LLC, Research Division Anna Lizzul - BofA Securities, Research Division Bonnie Herzog - Goldman Sachs Group, Inc., Research Division Olivia Tong Cheang - Raymond James & Associates, Inc., Research Division Robert Moskow - TD Cowen, Research Division Kevin Grundy - BNP Paribas, Research Division Presentation Operator Good day, ladies and gentlemen, and welcome to The Clorox Company First Quarter Fiscal Year 2026 Earnings Release Conference Call. [Operator Instructions].

Seekingalpha | 1 month ago
Clorox's System Change Dents Earnings, Sales

Clorox's System Change Dents Earnings, Sales

The cleaning-products company's first-quarter sales fell 19% to $1.43 billion as a result of shipment changes made in anticipation of an ERP system transition.

Wsj | 1 month ago
Clorox Q1 Earnings Preview: Can It Beat Estimates Amid Headwinds?

Clorox Q1 Earnings Preview: Can It Beat Estimates Amid Headwinds?

CLX braces for a tough Q1 as ERP transition, inventory reductions and macro headwinds weigh on sales and margins.

Zacks | 1 month ago
Analysts Estimate Clorox (CLX) to Report a Decline in Earnings: What to Look Out for

Analysts Estimate Clorox (CLX) to Report a Decline in Earnings: What to Look Out for

Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 month ago
Loading...
Load More